83 related articles for article (PubMed ID: 975103)
1. The significance of embryonic reexpression in cancer.
Medawar P; Hunt R
Cancer Res; 1976 Sep; 36(9 PT 2):3453-4. PubMed ID: 975103
[TBL] [Abstract][Full Text] [Related]
2. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
3. Proceedings: Third Conference on Embryonic and Fetal Antigens in Cancer. Introduction to session on cross-reactive antigens.
Medawar P
Cancer Res; 1974 Aug; 34(8):2053-4. PubMed ID: 4842255
[No Abstract] [Full Text] [Related]
4. Detection of tumor-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumor-free syngeneic mice. IV. Search for this antigen on syngeneic embryonic tissues.
Rejthar A
Folia Biol (Praha); 1974; 20(4):252-7. PubMed ID: 4412745
[No Abstract] [Full Text] [Related]
5. Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization.
Payne WJ; Coggin JH
J Natl Cancer Inst; 1985 Sep; 75(3):527-44. PubMed ID: 2411994
[TBL] [Abstract][Full Text] [Related]
6. [Growth of syngeneic transplantable tumors in Syrian hamsters immunized with hamster embryonic tissue].
Vendrov EL; Deĭchman GI
Biull Eksp Biol Med; 1978; 86(7):57-8. PubMed ID: 678653
[TBL] [Abstract][Full Text] [Related]
7. Embryonic antigens shared between chemically induced lymphosarcomas and fibrosarcomas of the mouse.
Ménard S; Colnaghi MI
J Natl Cancer Inst; 1975 Feb; 54(2):479-81. PubMed ID: 1172784
[TBL] [Abstract][Full Text] [Related]
8. Embryonic antigens in tumor immunity.
Della Porta G
Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923
[No Abstract] [Full Text] [Related]
9. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
10. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
[TBL] [Abstract][Full Text] [Related]
11. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.
Sato N; Kikuchi K
J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382
[TBL] [Abstract][Full Text] [Related]
12. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
13. Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice.
Nakatsura T; Komori H; Kubo T; Yoshitake Y; Senju S; Katagiri T; Furukawa Y; Ogawa M; Nakamura Y; Nishimura Y
Clin Cancer Res; 2004 Dec; 10(24):8630-40. PubMed ID: 15623647
[TBL] [Abstract][Full Text] [Related]
14. MMP11: a novel target antigen for cancer immunotherapy.
Peruzzi D; Mori F; Conforti A; Lazzaro D; De Rinaldis E; Ciliberto G; La Monica N; Aurisicchio L
Clin Cancer Res; 2009 Jun; 15(12):4104-13. PubMed ID: 19509157
[TBL] [Abstract][Full Text] [Related]
15. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte reactivity in normal and malignant cell proliferation against a phylogenetically conserved antigen in fetal extracts.
Pasternak G; Schlott B; Gryschek G; Albrecht S; Reinhöfer J; Matthes E; von Broen B
J Natl Cancer Inst; 1984 Apr; 72(4):901-8. PubMed ID: 6584664
[TBL] [Abstract][Full Text] [Related]
17. In vivo reexpression of H-2 antigens in B16 melanoma cells.
Lollini PL; Colombo MP; De Giovanni C; Nicoletti G; Parmiani G; Prodi G; Nanni P
Exp Clin Immunogenet; 1985; 2(1):14-23. PubMed ID: 3939971
[TBL] [Abstract][Full Text] [Related]
18. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.
Cohen PA; Cohen PJ; Rosenberg SA; Mulé JJ
Cancer Res; 1994 Feb; 54(4):1055-8. PubMed ID: 7906197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
